Average Co-Inventor Count = 5.24
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Five Prime Therapeutics, Inc. (10 from 71 patents)
2. Bristol-myers Squibb Compnay (5 from 3,684 patents)
10 patents:
1. 11566076 - Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected cancers
2. 11421034 - Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
3. 11235059 - Afucosylated anti-FGFR2IIIB antibodies
4. 10975153 - Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
5. 10730949 - Method of treating PVNS with anti-CSF1R antibodies
6. 10618967 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
7. 10221244 - Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
8. 10172937 - Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies
9. 10040858 - Anti-CSF1R antibodies for treating PVNS
10. 9765147 - Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer